Safety, Pharmacokinetics and Pharmacodynamics of DS-1040, in Combination with Thrombectomy, in Japanese Patients with Acute Ischemic Stroke
ConclusionsSingle doses of DS-1040 0.6 –4.8 mg were well tolerated in Japanese patients with AIS undergoing thrombectomy.Clinical trial registration numberNCT03198715; JapicCTI-163164.
Source: Clinical Drug Investigation - Category: Drugs & Pharmacology Source Type: research
More News: Bleeding | Clinical Trials | Drugs & Pharmacology | Hemorrhagic Stroke | Ischemic Stroke | Japan Health | Pulmonary Thromboembolism | Stroke | Study | Subarachnoid Hemorrhage